Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Effects of combined opioids on pain and mood in mammals.

Rech RH, Mokler DJ, Briggs SL.

Pain Res Treat. 2012;2012:145965. doi: 10.1155/2012/145965. Epub 2012 Mar 21.

2.

When is a grade 4 pressure ulcer not grade 4?

Briggs SL.

Br J Nurs. 2011 Nov 10-23;20(20):S4, S6, S8-9.

PMID:
22067935
3.
4.

Clinical perspective on silicone dressings and wound management.

Briggs SL, Taylor A, Lansdown AB.

J Wound Care. 2008 Aug;17(8):364-5; author reply 365-6. No abstract available.

PMID:
18754199
5.

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer.

Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM, Hostetter G, Boguslawski S, Moses TY, Savage S, Uhlik M, Lin A, Du J, Qian YW, Zeckner DJ, Tucker-Kellogg G, Touchman J, Patel K, Mousses S, Bittner M, Schevitz R, Lai MH, Blanchard KL, Thomas JE.

Nature. 2007 Jul 26;448(7152):439-44. Epub 2007 Jul 4.

PMID:
17611497
6.

How accurate are RGNs in grading pressure ulcers?

Briggs SL.

Br J Nurs. 2006 Dec 14-2007 Jan 10;15(22):1230-4.

PMID:
17346021
7.

Monitoring the ligand binding mode by proton NMR chemical shift differences.

Subramaniam S, Briggs SL, Kline AD.

ChemMedChem. 2006 Nov;1(11):1197-9. No abstract available.

PMID:
17001613
8.

A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta.

Wang Y, Chirgadze NY, Briggs SL, Khan S, Jensen EV, Burris TP.

Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9908-11. Epub 2006 Jun 16.

9.

The role of fibronectin in fibroblast migration during tissue repair.

Briggs SL.

J Wound Care. 2005 Jun;14(6):284-7. Review.

PMID:
15974416
10.

A novel glucokinase activator modulates pancreatic islet and hepatocyte function.

Efanov AM, Barrett DG, Brenner MB, Briggs SL, Delaunois A, Durbin JD, Giese U, Guo H, Radloff M, Gil GS, Sewing S, Wang Y, Weichert A, Zaliani A, Gromada J.

Endocrinology. 2005 Sep;146(9):3696-701. Epub 2005 May 26.

PMID:
15919746
11.

Leg ulcer management: how addressing a patient's pain can improve concordance.

Briggs SL.

Prof Nurse. 2005 Feb;20(6):39-41. Review.

PMID:
15726868
12.

Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions.

Leduc AM, Trent JO, Wittliff JL, Bramlett KS, Briggs SL, Chirgadze NY, Wang Y, Burris TP, Spatola AF.

Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11273-8. Epub 2003 Sep 17.

13.

Radiation protection and environmental management at the relativistic heavy ion collider.

Musolino SV, Briggs SL, Stevens AJ.

Radiat Prot Dosimetry. 2001;96(4):323-32.

PMID:
11843082
14.
15.

Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution.

Jin L, Briggs SL, Chandrasekhar S, Chirgadze NY, Clawson DK, Schevitz RW, Smiley DL, Tashjian AH, Zhang F.

J Biol Chem. 2000 Sep 1;275(35):27238-44.

16.
17.

The design of potent, selective, non-covalent, peptide thrombin inhibitors utilizing imidazole as a S1 binding element.

Wiley MR, Weir LC, Briggs SL, Chirgadze NY, Clawson D, Gifford-Moore DS, Schacht AL, Smith GF, Vasudevan V, Zornes LL, Klimkowski VJ.

Bioorg Med Chem Lett. 1999 Sep 20;9(18):2767-72.

PMID:
10509932
18.

Heterotopic pregnancy with term delivery after rupture of a first-trimester tubal pregnancy. A case report.

Chandra PC, Schiavello HJ, Briggs SL, Samuels JD.

J Reprod Med. 1999 Jun;44(6):556-8.

PMID:
10394552
19.

Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 2. Sidechain optimization and demonstration of in vivo efficacy.

Zhang M, Bailey DL, Bastian JA, Briggs SL, Chirgadze NY, Clawson DK, Denney ML, Gifford-Moore DS, Harper RW, Johnson LM, Klimkowski VJ, Kohn TJ, Lin HS, McCowan JR, Richett ME, Sall DJ, Smith AJ, Smith GF, Snyder DW, Takeuchi K, Utterback BG, Yan SC.

Bioorg Med Chem Lett. 1999 Mar 8;9(5):775-80.

PMID:
10201846
20.

Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 2. Exploring interactions at the proximal (S2) binding site.

Sall DJ, Briggs SL, Chirgadze NY, Clawson DK, Gifford-Moore DS, Klimkowski VJ, McCowan JR, Smith GF, Wikel JH.

Bioorg Med Chem Lett. 1998 Sep 22;8(18):2527-32.

PMID:
9873574
21.

Successful pregnancy outcome after complicated varicella pneumonia.

Chandra PC, Patel H, Schiavello HJ, Briggs SL.

Obstet Gynecol. 1998 Oct;92(4 Pt 2):680-2.

PMID:
9764662
22.

Antinociceptive effects of oxymorphone-butorphanol-acepromazine combination in cats.

Briggs SL, Sneed K, Sawyer DC.

Vet Surg. 1998 Sep-Oct;27(5):466-72.

PMID:
9749518
23.

Kappa antinociceptive activity of spiradoline in the cold-water tail-flick assay in rats.

Briggs SL, Rech RH, Sawyer DC.

Pharmacol Biochem Behav. 1998 Jun;60(2):467-72.

PMID:
9632230
24.

Dibasic benzo[b]thiophene derivatives as a novel class of active site-directed thrombin inhibitors. 1. Determination of the serine protease selectivity, structure-activity relationships, and binding orientation.

Sall DJ, Bastian JA, Briggs SL, Buben JA, Chirgadze NY, Clawson DK, Denney ML, Giera DD, Gifford-Moore DS, Harper RW, Hauser KL, Klimkowski VJ, Kohn TJ, Lin HS, McCowan JR, Palkowitz AD, Smith GF, Takeuchi K, Thrasher KJ, Tinsley JM, Utterback BG, Yan SC, Zhang M.

J Med Chem. 1997 Oct 24;40(22):3489-93. No abstract available.

PMID:
9357512
25.

The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.

Chirgadze NY, Sall DJ, Klimkowski VJ, Clawson DK, Briggs SL, Hermann R, Smith GF, Gifford-Moore DS, Wery JP.

Protein Sci. 1997 Jul;6(7):1412-7.

26.

Crystal structure of the obese protein leptin-E100.

Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK, DiMarchi RD, Furman TC, Hale JE, Hsiung HM, Schoner BE, Smith DP, Zhang XY, Wery JP, Schevitz RW.

Nature. 1997 May 8;387(6629):206-9.

PMID:
9144295
27.

Oxymorphone-induced analgesia and colonic motility measured in colorectal distension.

Briggs SL, Sawyer DC, Rech RH, Galligan JJ.

Pharmacol Biochem Behav. 1995 Nov;52(3):561-3.

PMID:
8545474
28.

Anti-tumor activity of CC49-doxorubicin immunoconjugates.

Johnson DA, Briggs SL, Gutowski MC, Barton R.

Anticancer Res. 1995 Jul-Aug;15(4):1387-93.

PMID:
7654026
29.

Site-specific prodrug activation by antibody-beta-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models.

Meyer DL, Jungheim LN, Law KL, Mikolajczyk SD, Shepherd TA, Mackensen DG, Briggs SL, Starling JJ.

Cancer Res. 1993 Sep 1;53(17):3956-63.

30.

Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs.

Apelgren LD, Bailey DL, Briggs SL, Barton RL, Guttman-Carlisle D, Koppel GA, Nichols CL, Scott WL, Lindstrom TD, Baker AL, et al.

Bioconjug Chem. 1993 Mar-Apr;4(2):121-6.

PMID:
7873643
31.

Long-term growth suppression of human glioma xenografts by chemoimmunoconjugates of 4-desacetylvinblastine-3-carboxyhydrazide and monoclonal antibody 9.2.27.

Schrappe M, Bumol TF, Apelgren LD, Briggs SL, Koppel GA, Markowitz DD, Mueller BM, Reisfeld RA.

Cancer Res. 1992 Jul 15;52(14):3838-44.

32.

In vivo antitumor activity of a panel of four monoclonal antibody-vinca alkaloid immunoconjugates which bind to three distinct epitopes of carcinoembryonic antigen.

Starling JJ, Maciak RS, Hinson NA, Nichols CL, Briggs SL, Laguzza BC, Smith W, Corvalan JR.

Bioconjug Chem. 1992 Jul-Aug;3(4):315-22.

PMID:
1382618
33.

Indoor exposures to fine aerosols and acid gases.

Koutrakis P, Brauer M, Briggs SL, Leaderer BP.

Environ Health Perspect. 1991 Nov;95:23-8.

34.
37.

New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activity.

Laguzza BC, Nichols CL, Briggs SL, Cullinan GJ, Johnson DA, Starling JJ, Baker AL, Bumol TF, Corvalan JR.

J Med Chem. 1989 Mar;32(3):548-55.

PMID:
2783975
38.

In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibody.

Starling JJ, Maciak RS, Hinson NA, Nichols CL, Briggs SL, Laguzza BC.

Cancer Immunol Immunother. 1989;28(3):171-8.

PMID:
2784353
39.

KS1/4-DAVLB, a monoclonal antibody-vinca alkaloid conjugate for site-directed therapy of epithelial malignancies.

Bumol TF, Baker AL, Andrews EL, DeHerdt SV, Briggs SL, Spearman ME, Apelgren LD.

Targeted Diagn Ther. 1988;1:55-79. Review. No abstract available.

PMID:
2979063
40.

Child sexual abuse prevention: does it work?

Swan HL, Press AN, Briggs SL.

Child Welfare. 1985 Jul-Aug;64(4):395-405.

PMID:
4017710
41.
42.

Letter: Calibration of glucose methods with lyophilized materials: a caution.

Swain RR, Carpenter RM, Briggs SL.

Clin Chem. 1976 Jun;22(6):926. No abstract available.

PMID:
1277486

Supplemental Content

Loading ...
Support Center